After the surprise departure of its founding CEO in August, Illumina spin-out Grail has named Roche/Genentech’s Global Head of Clinical Operations Jennifer Cook as its new leader.
Illumina spin-out Grail revealed Wednesday that Jeff Huber is stepping down as CEO of the billion-dollar early cancer detection startup.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Providence St. Joseph Health recently hired Microsoft executive Venkat Bhamidipati as CFO. His appointment points to a trend of healthcare organizations eyeing the tech sector for new talent.
In a phone interview, Huber shared that he believes his experience with Google, in different areas over 13 years, set him up to be very conscious of analytics and looking at specific data, which will be an asset to Grail in determining the efficacy of future clinical trials.
Also, CTI BioPharma Corp said the U.S Food and Drug Administration has put a full clinical hold on the company's investigational new drug application for pacritinib.